Microbubble/Ultrasound Contrast Agents Market 2018: Perform of Upcoming Years based on Market Size, Type, Application and Major Regions.


Posted February 22, 2019 by savibangar

The Global Microbubbles/Ultrasound Contrast Agents Market will grow at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024

 
The Global Microbubbles/Ultrasound Contrast Agents Market will grow at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024, according to the latest publication from Meticulous Research®.

The field of ultrasound contrast imaging has been literally bursting since the last decade. The advancement in ultrasound technologies over the last decade have resulted in widespread usage of ultrasound contrast imaging for clinical applications. This technology is preferred by most researchers due to low-cost, convenience, and real-time capability. In addition, as compared to imaging modalities, ultrasound imaging has good temporal resolution, quantitative data, real-time practice, noninvasiveness, relatively inexpensive, and no ionizing radiation. Also, it was reported by researchers that they help to sharp the image, improve the reliability of the scan, and reduce the need for unnecessary downstream testing. They found to be safe, convenient, completely radiation-free, and versatile. Owing to all these benefits, researchers are trying to use them for diagnostic imaging and other therapeutic areas.

For detail information visit on our web-site
https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-2024/

The global microbubbles/ultrasound contrast agents market is driven by various factors such as advancement in ultrasound technologies, benefits of ultrasound over alternative technologies, increase in demand for diagnostics & image guided procedures, favorable reimbursement policies for contrast enhanced procedures in the U.S., and growing aging population and subsequent rise in the prevalence of chronic diseases. In addition, rising research activities related to microbubbles/ultrasound contrast agents and emerging economies in the Asia Pacific region provides significant opportunities for various stakeholders in this market.

The global microbubbles/ultrasound contrast agents market studied in this report is majorly segmented on the basis of therapeutic area (cardiovascular diseases, renal and associated diseases, and others), application (molecular imaging, gene therapy, drug delivery, and stem cells delivery), and geography.

The key players analyzed in the microbubble/ultrasound contrast agents market are Lantheus Holdings, Inc. (U.S.), Bracco (Italy), GE Healthcare (U.S.), Daiichi Sankyo Company, Limited (Japan), and nanoPET Pharma GmbH (Germany).

For detail analysis and market values, download free sample report @
https://www.meticulousresearch.com/download-sample-report/?cp_id=3732

Contact –
Khushal Bombe
[email protected]
Office No-402, 4th Floor,
Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Savi Bangar
Phone +1-646-781-8004
Country India
Categories Industry , Marketing , Research
Tags cardiovascular diseases , drug delivery , market research , microbubbleultrasound contrast agents market , molecular imaging , pharma , pharmaceutical , research
Last Updated February 22, 2019